ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
stockNASDAQ
founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company's aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.73 | 2026-10-22 | +12.30% | 12.359 |
| 1M | 13.70 | 2026-09-29 | -12.04% | 5.876 |
| 3M | 5.79 | 2026-07-29 | +108.12% | 2.470 |
| 6M | 8.40 | 2026-04-29 | +43.45% | 2.065 |
| 1Y | 9.44 | 2025-10-29 | +27.65% | 1.963 |
| 2Y | 19.12 | 2024-10-29 | -36.98% | — |
| 5Y | 44.95 | 2021-10-29 | -73.19% | 1.923 |
Arcturus Therapeutics Holdings Inc. Common Stock (NASDAQ:ARCT) stock price today is $12.05, and today's volume is 714,983. ARCT is up 7.302% today. The 30 day average volume is 747,699. ARCT market cap is $342.50M with 28.42M shares outstanding.